Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.06 | N/A |
| PEG Ratio (TTM) | 0.01 | N/A |
| P/S Ratio (TTM) | 0.00 | N/A |
| P/B Ratio (TTM) | -0.06 | N/A |
| P/FCF Ratio (TTM) | -0.32 | N/A |
| Price to 5YR AVG Earnings Ratio | -1.00 | N/A |
| Price to 5YR AVG FCF Ratio | -0.52 | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.96% | N/A |
| ROE (TTM) | -5.85% | N/A |
| Net Profit Margin (TTM) | 0.42% | N/A |
| ROIC 5YR AVG | 9.21% | N/A |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -176.31% | -52.48% | -21.08% |
| Revenue | -5.61% | -2.52% | 1.66% |
| Net Income | -173.52% | -49.69% | -26.61% |
| Cash Flow | -57.91% | 95.89% | 278.95% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.27 | N/A |
| Quick Ratio (TTM) | 1.27 | N/A |
| D/E Ratio (TTM) | -3.47 | N/A |
| Interest Coverage (TTM) | 1.21 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 0.18 | N/A |
| LTL to 5YR AVG FCF | -14.07 | N/A |
| Shares Outstanding Growth 5YR AVG | 9.75% | N/A |